Results for Renoprotective

Astaxanthin promotes Nrf2/ARE signalling to inhibit high glucose induced renal fibrosis in GMCs.

Article Published Date : Apr 04, 2018
Study Type : Animal Study
Additional Links
Substances : Astaxanthin : CK(1010) : AC(437)
Diseases : Diabetic Nephropathy : CK(707) : AC(277), Kidney Fibrosis : CK(121) : AC(68)
Pharmacological Actions : Antioxidants : CK(21528) : AC(8856), Nrf2 activation : CK(1584) : AC(916), Renoprotective : CK(2404) : AC(1075)
Additional Keywords : Antioxidants : CK(303) : AC(126), Astaxanthin, Diabetic Nephropathy, Kidney Fibrosis, Nrf2 activation, Renoprotective

Combination therapy of rosmarinic acid and lycopene shows better protective effects than the corresponding monotherapy.

Article Published Date : Nov 23, 2016
Study Type : Animal Study
Additional Links
Substances : Lycopene : CK(886) : AC(249), Rosmarinic acid : CK(47) : AC(26)
Diseases : Chemotherapy-Induced Toxicity: Gentamicin : CK(146) : AC(75)
Pharmacological Actions : Chemoprotective Agents : CK(2322) : AC(906), Renoprotective : CK(2404) : AC(1075)
Additional Keywords : Chemoprotective Agents, Chemotherapy-Induced Toxicity: Gentamicin, lycopene, Renoprotective, Rosmarinic acid

Ginsenosides Rk2 and Rh3 have kidney protective effects of against cisplatin.

Article Published Date : Mar 31, 2017
Study Type : In Vitro Study
Additional Links
Substances : Ginsenosides : CK(1550) : AC(873)
Diseases : Chemotherapy-Induced Toxicity: Cisplatin : CK(881) : AC(388)
Pharmacological Actions : Chemoprotective Agents : CK(2322) : AC(906), Renoprotective : CK(2404) : AC(1075)
Additional Keywords : Chemoprotective Agents, Chemotherapy-Induced Toxicity: Cisplatin, Ginsenosides, Renoprotective

Ginsenosides Rk3 and Rh4 protect the kidney from cisplatin-induced oxidative injury.

Article Published Date : Jun 30, 2017
Study Type : Animal Study, In Vitro Study
Additional Links
Substances : Ginsenosides : CK(1550) : AC(873)
Diseases : Chemotherapy-Induced Toxicity: Cisplatin : CK(881) : AC(388)
Pharmacological Actions : Antioxidants : CK(21528) : AC(8856), Chemoprotective Agents : CK(2322) : AC(906), Renoprotective : CK(2404) : AC(1075)
Additional Keywords : Antioxidants : CK(303) : AC(126), Chemoprotective Agents, Chemotherapy-Induced Toxicity: Cisplatin, Ginsenosides, Renoprotective

Piceatannol provides remarkable renoprotection in diabetes by abrogating oxidative stress and NF-kB activation.

Article Published Date : Nov 25, 2016
Study Type : Animal Study
Additional Links
Substances : Piceatannol : CK(23) : AC(0)
Diseases : Diabetic Nephropathy : CK(707) : AC(277)
Pharmacological Actions : Anti-Inflammatory Agents : CK(20859) : AC(8334), Antioxidants : CK(21528) : AC(8856), NF-kappaB Inhibitor : CK(3536) : AC(2098), Renoprotective : CK(2404) : AC(1075)
Additional Keywords : Anti-Inflammatory Agents, Antioxidants : CK(303) : AC(126), Diabetic Nephropathy, NF-kappaB Inhibitor, Piceatannol, Renoprotective

Pterocarpus marsupium extract showed a promising antioxidant effect, as well as hypoglycemic activity.

Article Published Date : Oct 31, 2015
Study Type : Animal Study
Additional Links
Substances : Pterocarpus marsupium : CK(39) : AC(17)
Diseases : Hyperglycemia : CK(1494) : AC(453)
Pharmacological Actions : Antioxidants : CK(21528) : AC(8856), Hypoglycemic Agents : CK(5366) : AC(1338), Renoprotective : CK(2404) : AC(1075)
Additional Keywords : Antioxidants : CK(303) : AC(126), hyperglycemia, Hypoglycemic Agents, Phytotherapy : CK(3062) : AC(812), Plant Extracts : CK(14140) : AC(5210), Pterocarpus marsupium, Renoprotective

Puerarin seems to have certain protective effects on diabetic nephropathy.

Article Published Date : Dec 31, 2008
Study Type : Animal Study
Additional Links
Substances : Puerarin : CK(547) : AC(270)
Diseases : Diabetic Nephropathy : CK(707) : AC(277)
Pharmacological Actions : Renoprotective : CK(2404) : AC(1075)
Additional Keywords : Diabetic Nephropathy, Puerarin, Renoprotective

This provides evidence for the protective mechanism of L-carnitine in eliminating PFOS-mediated renal injury.

Article Published Date : Dec 31, 2015
Study Type : Animal Study, In Vitro Study
Additional Links
Substances : Carnitine : CK(494) : AC(81)
Diseases : Kidney Damage: Chemically-Induced : CK(25) : AC(13)
Pharmacological Actions : Renoprotective : CK(2404) : AC(1075)
Additional Keywords : Carnitine, Kidney Damage: Chemically-Induced, Perfluorooctane sulfonate (PFOS), Renoprotective
Problem Substances : Perfluorooctane sulfonate (PFOS) : CK(20) : AC(2)

Connect with GreenMedInfo

MeWe

This website is for information purposes only. By providing the information contained herein we are not diagnosing, treating, curing, mitigating, or preventing any type of disease or medical condition. Before beginning any type of natural, integrative or conventional treatment regimen, it is advisable to seek the advice of a licensed healthcare professional.

© Copyright 2008-2021 GreenMedInfo.com, Journal Articles copyright of original owners, MeSH copyright NLM.